Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas

Autor: Le Guyader, Guillaume, Vieillard, Victoire, Andrieux, Karine, Rollo, Mylène, Thirion, Olivier, Wolkenstein, Pierre, Paul, Muriel

Publikováno v: European Journal of Hospital Pharmacy
European Journal of Hospital Pharmacy, BMJ Group, 2018, 27 (e1), pp.e48-e52. ⟨10.1136/ejhpharm-2018-001695⟩
European Journal of Hospital Pharmacy, 2018, 27 (e1), pp.e48-e52. ⟨10.1136/ejhpharm-2018-001695⟩

International audience; Objectives : In recent years, various formulations containing rapamycin were tested, mainly with petrolatum to treat facial angiofibromas in tuberous sclerosis, especially in children. Nevertheless, a weak tolerance was found

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7b3806e117637df9207ea23516b3585e
https://hal.archives-ouvertes.fr/hal-03041293/file/Article_VF.pdf